Determination of Changes in Tissue Perfusion at Home with Hyperspectral and Thermal Imaging in the First Six Weeks after Endovascular Therapy in Patients with Peripheral Arterial Disease.
Kirsten F MaThomas S NijboerSimone F KleissMostafa El MoumniReinoud P H BokkersRichte C L SchuurmannJean-Paul P M de VriesPublished in: Diagnostics (Basel, Switzerland) (2022)
The aims of this study were to assess changes in tissue perfusion up to 6 weeks after endovascular therapy (EVT), in hospital and at home, and to determine differences in tissue perfusion between patients with and without clinical improvement or good angiographic result. This single-center prospective cohort study included patients undergoing EVT for Rutherford stages two to six. Hyperspectral and thermal imaging were performed at the dorsal and plantar sides of the foot. These measurements consisted of a baseline measurement pre-EVT, and six follow-up measurements obtained at 1 and 4 h and 6 weeks in hospital, and 1 day, 7 days, and 14 days at home. Clinical improvement was defined as a decrease of one or more Rutherford class or decrease in the wound surface area and a good angiographic result was accomplished when a Transatlantic Inter-Society Consensus for the Management of PAD II C or D lesion was treated and uninterrupted flow continued in at least one below-the-knee artery in continuation with the inframalleolar arteries. The study included 34 patients with 41 treated limbs. Deoxyhemoglobin values were lower 1 h post-EVT compared with baseline and increased over time up to 6 weeks post-EVT. Significant differences in deoxyhemoglobin levels at 7 and 14 days post-EVT were determined between patients with and without clinical or angiographic success. This prospective pilot study shows the feasibility of hyperspectral imaging and thermal imaging post-EVT at home, which may decrease the need for hospital visits.
Keyphrases
- high resolution
- patients undergoing
- healthcare
- gestational age
- contrast enhanced
- total knee arthroplasty
- stem cells
- computed tomography
- spinal cord injury
- mesenchymal stem cells
- adverse drug
- mass spectrometry
- photodynamic therapy
- fluorescence imaging
- knee osteoarthritis
- venous thromboembolism
- atrial fibrillation
- electronic health record
- preterm birth